Your browser doesn't support javascript.
loading
Non-clinical evaluation of JR-051 as a biosimilar to agalsidase beta for the treatment of Fabry disease.
Morimoto, Hideto; Ito, Yae; Yoden, Eiji; Horie, Masato; Tanaka, Noboru; Komurasaki, Yoshikazu; Yamamoto, Ryuji; Mihara, Kazutoshi; Minami, Kohtaro; Hirato, Tohru.
  • Morimoto H; Research Division, JCR Pharmaceuticals, 2-2-9 Murotani, Nishi-ku, Kobe 651-2241, Japan.
  • Ito Y; Research Division, JCR Pharmaceuticals, 2-2-9 Murotani, Nishi-ku, Kobe 651-2241, Japan.
  • Yoden E; Research Division, JCR Pharmaceuticals, 2-2-9 Murotani, Nishi-ku, Kobe 651-2241, Japan.
  • Horie M; Research Division, JCR Pharmaceuticals, 2-2-9 Murotani, Nishi-ku, Kobe 651-2241, Japan.
  • Tanaka N; Research Division, JCR Pharmaceuticals, 2-2-9 Murotani, Nishi-ku, Kobe 651-2241, Japan.
  • Komurasaki Y; Research Division, JCR Pharmaceuticals, 2-2-9 Murotani, Nishi-ku, Kobe 651-2241, Japan.
  • Yamamoto R; Research Division, JCR Pharmaceuticals, 2-2-9 Murotani, Nishi-ku, Kobe 651-2241, Japan.
  • Mihara K; Research Division, JCR Pharmaceuticals, 2-2-9 Murotani, Nishi-ku, Kobe 651-2241, Japan.
  • Minami K; Research Division, JCR Pharmaceuticals, 2-2-9 Murotani, Nishi-ku, Kobe 651-2241, Japan. Electronic address: minami-k@jcrpharm.co.jp.
  • Hirato T; Research Division, JCR Pharmaceuticals, 2-2-9 Murotani, Nishi-ku, Kobe 651-2241, Japan. Electronic address: hirato-t@jcrpharm.co.jp.
Mol Genet Metab ; 125(1-2): 153-160, 2018 09.
Article en En | MEDLINE | ID: mdl-30054149

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Enfermedad de Fabry / Alfa-Galactosidasa / Biosimilares Farmacéuticos / Isoenzimas Tipo de estudio: Prognostic_studies Límite: Animals / Humans / Male Idioma: En Año: 2018 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Enfermedad de Fabry / Alfa-Galactosidasa / Biosimilares Farmacéuticos / Isoenzimas Tipo de estudio: Prognostic_studies Límite: Animals / Humans / Male Idioma: En Año: 2018 Tipo del documento: Article